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Abstract
Background: Hospital care plays a major role at the end-of-life. But little is known about the overall size and
characteristics of the palliative inpatient population. The aim of our study was to analyse these aspects.
Methods: We conducted a one-day observational study in 14 randomly selected Belgian hospitals. Patients who
met the definition of palliative patients were identified as palliative. Then, information about their socio-
demographic characteristics, diagnoses, prognosis, and care plan were recorded and analysed.
Results: There were 2639 in-patients on the day of the study; 9.4% of them were identified as “palliative”. The
mean age of the group was 72 years. The primary diagnosis was cancer in 51% of patients and the estimated life
expectancy was shorter than 3 months in 33% of patients and longer than 1 year in 28% of patients. The
professional caregivers expected for most of the patients (73%), that the treatment would improve patient comfort
rather than prolong life. Antibiotics, transfusions, treatments specific to the pathology, and artificial nutrition were
administered in 90%, 78%, 57% and 50% of the patients, respectively, but were generally given with a view to
controlling the symptoms.
Conclusions: This analysis presents a first national estimate of the palliative inpatient population. Our results
confirm that hospitals play a major role at the end-of-life, with one out of ten inpatients identified as a “palliative”
patient. These data also demonstrate the complexity of the palliative population and the substantial diversity of
care that they can require.
Background
WHO defined palliative care as ‘’the active total care of
patients whose disease is not responsive to curative
treatment’ [1]. In Belgium, palliative care relies on this
definition and is provided in different settings: home
care, residential units or hospices. These 51 residential
units have 379 palliative beds, i.e. an insufficient number
of beds in view of the palliative care demand. Therefore,
every acute hospital is subsidized for an intramural pal-
liative support team. Recently, 6 day centres have been
created in Belgium. All these services are specialized in
the care of palliative patients with more complex needs.
The patients not treated in these services are treated in
classic structures providing palliative care but not spe-
cialized in palliative care (general hospital wards, home
care nursing services, general practitioners, nursing
homes...) [2]. Beside the specialised palliative services,
the country is divided into 25 areas, called palliative net-
works, each covering around 300.000 inhabitants. These
networks coordinate the intervention of palliative care
services and integrate them into the health care system.
Each network has its own home care team.
Even though more than 70% of Belgian population
would prefer to be treated at home, a large number of
deaths occur in hospital [3]. A considerable amount of
information regarding palliative inpatients is available
and the place of death and its determinants in this spe-
cific context have been extensively investigated [4]. Van
den Block et al. reported on the institutionalised nature
of the final phase of life and concluded that clinical con-
dition, expression of preferences, and characteristics of
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transfer of such patients to the hospital [5]. However,
the wider use of the hospital setting in providing pallia-
tive care has been less frequently considered. Most of
the previous studies have been limited to specific diag-
noses (e.g., cancer), age groups (e.g., the elderly), or set-
tings (e.g., specialist palliative care services). Although
some surveys have included the number of palliative
inpatients, they do not give a global overview as they
were all conducted in one single or in a university hos-
pital [6-10]. Furthermore, two of them have focused
only on terminally ill patients and another study was
specifically interested in the need for specialist inpatient
palliative care [6,7,10].
The purpose of this study was to assess the overall
population of hospital palliative inpatients who should
benefit from palliative care and to describe their main
demographic and medical characteristics.
Methods
The study was prospective and data was collected by
interviews conducted with medical and nursing staff.
The literature shows that the proportion of cancer
patients among palliative inpatients varies around 50%
[6]. The sample size was computed to detect a 25% dif-
ference between the proportions of cancer and non can-
cer patients. With a hypothesis of type I error equal to
0.05 and a power equal to 0.80, the sample size should
be 364 palliative patients. In order to estimate the num-
ber of beds to include, we chose a proportion of pallia-
tive patients of 10% as this proportion varies between
5% and 15% in the literature [6,9]. This would lead to
investigate 364/0.10 = 3640 inpatients. Taking an occu-
pation rate of 0.75 entails that 4842 beds should be
checked.
Fourteen hospitals were randomly selected from all
Belgian hospitals, taking into account the type (aca-
demic/non academic; acute/non acute), the size (< 300
beds, 300-500 beds and >500 beds), and the geographi-
cal location (Brussels, Flanders and Wallonia). Twelve
categories were created based on these hospital’s charac-
teristics and each Belgian hospital was allocated to a sin-
gle category. The hospital sample was built by a random
selection of one hospital in each category. Finally, a uni-
versity hospital from Flanders and another from Wallo-
nia were added to the sample.
Two non university hospitals refused to participate
and were replaced by 2 other hospitals randomly
selected in the corresponding categories.
All hospital beds were included (4746 beds), except
obstetrics and psychiatry as such wards are only rarely
involved in palliative care. Intensive care units were also
excluded although these units present a high death rate
and in spite of innovative and specific palliative care
programs [11]. Indeed the survey design was not
adapted to this type of patients and treatments (prog-
nostic uncertainties, specific life-sustaining treatment...).
Paediatric and neonatology units were also not eligible
due to their specific care plans. As we intended to mea-
sure the frequency of patients who could be considered
as palliative and therefore should benefit from a pallia-
tive care program, the palliative units were not included
in this survey. All patients hospitalised in an eligible
unit for at least 48 hours (i.e. enough time for the physi-
cians and the nurses to know the patient) were included
in the study. Patients undergoing in-hospital transfer
during the same stay were included only once.
The Ethics Committee of St Luc Hospital-UCL gave a
positive opinion to the protocol which was registered in
the National Federal Experimentation Data Bank of the
National Ethics Committee under the number
B40320084090. The study was performed according the
different Belgian laws concerning confidentiality and
private life (2002), patients’ rights (2002) and experi-
mentation on human beings (2004). This study was a
sub-project of a larger one which was asked by the pro-
moter, the Belgian Health Care Knowledge (KCE).
Three specifically appointed nurses conducted the sur-
vey in 2008, over a 3-month period. After hospital
approval, the caregivers of each ward included in the
survey were interviewed once on a certain day fixed in
advance. In small hospitals with few wards, all inter-
views were conducted in a single day. Larger hospitals
with a greater number of wards to be surveyed required
more time. Only 3 physicians refused to participate, i.e.
less than 1% of the physicians contacted.
The study nurses interviewed the nurses and physi-
cians who were in charge of the patients and had daily
contact with them. Firstly, the nurses and physicians
were separately asked to assess whether that patient met
the definition of a palliative patient.
In 2002, the World Health Organisation defined pal-
liative care as “an approach that improves the quality of
life of patients and their families facing the problem
associated with life-threatening illness through the pre-
vention and relief of suffering by means of early identifi-
cation, impeccable assessment and treatment of pain
and other problems physical psychosocial and spiritual”
[12]. This definition is broader than the one given by
the World Health Organisation in (1990): “Palliative
care is the active total care of patients whose disease is
not responsive to curative treatment” [1]. In Belgium,
even though the notion of palliative patient is not offi-
cially defined, preferential reimbursement rate are
granted to the patient having a ‘palliative’ status. As
m e n t i o n e db yK e i r s ee ta l .a n db yP a s t r a n ae ta l . ,t h e r e
is no current consensus about the definition of palliative
patient [13,14]. Therefore within the context of our
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fering from an incurable, progressive, life-threatening
disease, with no possibility of obtaining remission, sta-
bilization or improvement of this illness”.T h et e r m
“incurable“ excluded illnesses for which there is a
chance of complete cure; the term “progressive“ elimi-
nated chronic, incurable but stable disease; the terms
“no possibility of obtaining remission, stabilization or
improvement of the illness“ highlighted the ineffective-
ness of specific therapeutics to control the disease [15];
and the term “life-threatening disease” introduced a
notion of survival prediction and fatal outcome. This
last notion could not be defined in a more precise way
due to the difficulty in giving an accurate prognosis
except when the patient is very close to death [16].
This definition of “palliative patient” does not include
any criterion based on patient needs because we con-
sidered this aspect too difficult to define precisely, as it
would have required taking into account many other
factors deemed by the caregivers to be related to pal-
liative care [17].
The second part of the study was carried out in
respect of those patients who met these four criteria.
The study nurses made an interview of the same
caregivers using a structured questionnaire. The ques-
tionnaire collected data relating to the patient’ss o c i o -
demographic characteristics,d i a g n o s e s ,p r o g n o s i s ,a n d
care plan. The questionnaire can be found in annex
(File 1: English version; File 2: French version).
In order to avoid any (mis)interpretation of the pallia-
tive patient’s definition, the term ‘palliative’ was not
used during the interview of the caregivers. The inter-
viewer presented to the caregivers a paper mentioning
the 4 abovementioned criteria of our definition. Then
the caregivers reviewed if the patient met each of the
four criteria presented.
Before the beginning of the hospital survey, the ques-
tionnaire was first tested in 2 hospitals not included in
the survey’s sample. Then, the study nurses performed
in one hospital under the supervision of the survey’s
designer. Finally, during the survey, regular meetings
were organised between the study nurses and the sur-
vey’s designer.
Univariate and multivariate statistics were performed
to analyse the data. Pearson’s chi square test was used
to detect statistical differences between groups as the
data were primarily categorical. Comparisons of age
b e t w e e ng r o u p sw e r em a d eu s i n gt h eW i l c o x o n ’st e s t .
Multivariate logistic regression was also used to test the
effects of various factors on the intention to prolong
life. The covariates introduced in the model were age,
sex, pathology, prognosis and type of bed. The analysis
was made with SAS version 9.1 and a p-value equal or
less than 0.05 was considered as significant.
Results
Prevalence of palliative patients
Two-hundred and forty-nine in-patients were identified
as “palliative” by the medical and nursing staff, compris-
ing 9.4% of the total in-patient population. Table 1
shows that the prevalence of palliative patients was sig-
nificantly less in surgical and rehabilitation beds than in
medical and geriatric beds. The prevalence also varied
significantly among regions. One Brussels’ hospital had
a particularly high prevalence value. After exclusion of
this ‘outlier’, there were no significant differences in the
prevalence of palliative patients between university and
other hospitals, private or public institutions, and hospi-
tals with or without a palliative care unit.
Patients’ characteristics
Of the 249 palliative patients, 55% (136/249) were
female and the mean age was 72 years with a range of
21 to 99. The majority of patients were older than 65
years (175/249) with a considerable number older than
80 (93/249). About half of the patients were married
(112/239) and the others were widowed (79), divorced
(14) or single (34). Seventy percent of patients (174/249)
had been admitted from home and 30% from another
residence, such as a nursing home.
The primary diagnoses are shown in Table 2.
Approximately half of the patients had a primary diag-
nosis of cancer. The most common non-cancer diag-
noses were dementia, stroke, and cardiac, respiratory or
hepatic failure. Cancer patients were significantly
younger than the non-cancer patients (68 ± 14 versus
77 ± 13 years, p < 0.0001) and mainly hospitalised in
medical beds (81/128). Patients suffering from dementia
and stroke were significantly older than the other pallia-
tive patients (82 ± 9 years versus 70 ± 15 years, p <
0.0001) and were largely hospitalised in geriatric beds
(34/49) (Figure 1).
For almost one third of patients (71/242), the diagno-
sis had been established 3 months before the current
hospitalisation and for half of them (112/242), it had
been established during the year prior to the study.
As illustrated in Table 3 the estimated life expectancy
varied from less than 7 days to more than 5 years. One
third of patients had a life expectancy of three months
or less and, from the primary diagnosis, one half of
patients would be expected to still be alive after six
months (Figure 2). The prognosis was less than 1 year
for 88% of cancer patients and for 56% of non-cancer
patients (p < 0.0001).
Patients’ treatment
The caregivers had already established a treatment plan
for 220 of the 249 patients (88%) before the interview.
The plan had been discussed by physicians and nurses
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(11%). These percentages were independent of the
pathology, survival prognosis, or expectations of the
treatment plan.
When analysing the expectations of the treatment plan,
it appears that the goal of physicians and nurses was to
improve patient comfort rather than prolonging life.
Multivariate logistic regression analysis showed that
treatment expectations depended mainly on the patient’s
prognosis (OR = 1.760, CL = 1.360 - 2.279). For the 79
patients with a survival prognosis less than 3 months, an
expectation of prolonging life was reported in just 6.3%
of cases (5/79), while for the 67 patients with a prognosis
of at least 1 year, the expectation of prolonging life was
reported in 41.8% of cases. No significant differences in
expectations were observed comparing cancer to non-
cancer patients (Table 4); however, the caregivers more
frequently reported an expectation to prolong life in
patients with stroke (6/17) or organ system failure (20/
50) than in patients with dementia (1/32).
The type of treatment was generally clearly documen-
ted and defined by the professional caregivers. Cardiac
resuscitation was excluded for 71% of patients (177/
249). Antibiotics, transfusions, treatments specific to the
causative pathology (e.g., chemotherapy for cancer
patients), artificial nutrition, and transfer to the intensive
care unit were being considered, had been planned, or
were ongoing in 90% (224/249), 78% (195/249), 57%
(142/249), 50% (124/249) and 33% (81/249) of patients,
respectively. These interventions were administered in
order to control symptoms in 66% (149/224), 74% (144/
195), 56% (80/142), 45% (56/124) and 25% (20/81) of
the cases, respectively. Table 5 shows the proportion of
patients for which treatments were excluded depending
on their prognosis. In case of very poor prognosis, car-
diac resuscitation and transfer to intensive care unit
were excluded for all patients. These 2 treatments were
excluded for more than half of patients whatever their
prognosis.
Discussion
Several limitations should be mentioned when interpret-
ing these results. The first is a possible bias in the recruit-
ment of patients. The initial sample size calculations gave
an estimate of at least 3640 beds to recruit 364 palliative
patients. The final sample size was smaller, i.e. 249
patients, for two reasons. The mean bed occupation rate
was lower than expected; the study excluded patients
with a length of stay less than 48 hours (25% of patients
in some acute hospitals). The second limitation is related
to the fact that only the health care providers were inter-
viewed and therefore, the survey inaccurately reflects
patient treatment preferences. The third limitation con-
cerns the method of patient selection. We quantified the
Table 1 Prevalence of palliative inpatients
N Palliative Patients Non Palliative Patients p-value
Type of beds Surgery 727 16 (2.2%) 711(97.8%) p ≤ 0,001
Rehabilitation 488 22 (4.5%) 466 (95.5%)
Medicine 1015 134 (13.2%) 881 (86.8%)
Geriatric 409 77 (18.8%) 332 (81.2%)
Region Flanders 624 49 (7.9%) 575 (92.1%) p ≤ 0,001
Wallonia 692 56 (8.1%) 636 (91.9%)
Brussels 534 85 (15.9%) 449 (84.1%)
Palliative care unit With 1614 166 (10.3%) 1448 (89.7%) p = 0.0610
Without 1025 83 (8.1%) 942 (91.9%)
Social status Public 1111 96 (8.6%) 1005 (91.4%) p = 0.2338
Private 1528 153 (10.0%) 1375 (90.0%)
Table 2 Distribution of primary diagnoses
Cancer diagnoses 128 (51.4%)
Solid tumour 108 (43.4%)
Haematological cancer 19 (7.6%)
Non-cancer diagnoses 121 (48.6%)
Dementia 32 (12.9%)
Stroke 17 (6.8%)
Organ system failure 50 (20.0%)
Cardiac failure 16 (6.4%)
Respiratory failure 16 (6.4%)
Hepatic failure 13 (5.2%)
Renal failure 5 (2.0%)
Other diseases 40 (16.0%)
Neurological diseases 8 (3.2%)
Vascular diseases 6 (2.4%)
Infectious diseases 2 (0.8%)
Others 6 (2.4%)
Total 249 (100%)
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the same hospitals more than once would have provided
a more precise measure.
Nevertheless, this is the first survey to explore the
number and characteristics of palliative inpatients at a
national level. Slightly less than one out of ten inpatients
was identified as palliative. Similar percentages have
been reported from other surveys but these were con-
ducted in just one institution. Morize et al included all
patients with advanced or terminal stage life-threatening
illness who were hospitalised in a large French univer-
sity hospital [6]. These authors reported that 13% of the
inpatients were palliative patients. A similar percentage
(12%) was observed by Edmonds et al. and by Billings et
al in an English and an American academic hospital,
respectively [7,8]. In a study by Gott and colleagues, the
prevalence of palliative patients was higher (22%), but
the inclusion criteria in this study were based on need
for supportive and palliative care [9]. Similarly, Skilbek
et al. concentrated on specialist palliative care services
and observed that 4% of in-patients were considered sui-
table for referral to a palliative care unit [10].
As expected, the largest numbers of palliative in-
patients were admitted to geriatric beds. Metropolitan
hospitals also had greater number of palliative patients,
supporting the findings of Houtekkier et al. who con-
cluded that palliative patients died in hospital more
often in Brussels than in other parts of country [18].
As mentioned in the section ‘method’,o n eh o s p i t a l
was considered as an ‘outlier’. This hospital holds 22%
of Brussels’ palliative beds and was the pioneer of in-
hospital palliative care in the country. The higher pro-
portion of palliative patients observed in this hospital
could be due to a different culture about palliative care.
The second aim of the present study was to describe
the demographic and clinical characteristics of the pal-
liative inpatients. Our results show that the palliative
inpatient population is complex. A large number of can-
cer and non-cancer pathologies are represented, con-
trary to what is usually described in specialist palliative
care services [19,20]. As in previous reports, cancer was
the leading diagnosis in our study but nearly half the
patients had a non-malignant disease [6,9]. Despite their
typically insidious onset, prolonged disease trajectory
and difficulty in predicting life expectancy, chronic ill-
nesses are major causes of death in developed countries
today [21-23]. Moreover, persons dying from chronic ill-
ness tend to have frequent exacerbations requiring hos-
pitalisation. There is evidence suggesting that these
patients may require palliative care, just as those who
suffer from malignant disease [24]. In view of these find-
ings, palliative care in hospital cannot be confined to
one patient group and professional caregivers need to
acquire sufficient expertise to meet the common but
also the specific needs of cancer and non-cancer
patients [13].
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
All Cancer Dementia Stroke Cardiac
Failure
Respiratory
Failure
Hepatic
Failure
85-100 years
80-84 years
75-79 years
65-74 years
55-64 years
0-54 years
Figure 1 Age distributions of palliative patients by diagnostic group. The first bar represents the distribution of age of all palliative patients
whatever the disease. The others display the distribution of age for the most frequent underlying diseases.
Table 3 Distribution of estimated life expectancy
< 7 days 10 (4.1%) 79 (32.5%)
> 1 and ≤ 4 weeks 24 (9.9%)
> 1 and ≤ 3 months 45 (18.5%)
> 3 and ≤ 6 months 40 (16.5%) 97 (40.0%)
> 6 and ≤ 12 months 57 (23.5%)
> 1 and ≤ 5 years 62 (25.5%) 67 (27.5%)
> 5 years 5 (2.0%)
Total 243 (100%)
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remains quite difficult, our results show considerable
variation in the life-expectancy of our palliative popula-
tion [16]. One third of the palliative inpatients had a life
expectancy of 3 months or less. These patients can be
considered “terminally ill patients” as they are referred
to in the current literature. For approximately another
one third of patients, the physicians and nurses consid-
ered the survival prognosis to be more than one year.
Nevertheless, in 70% of all the palliative patients, the
treatment plan aimed at improving symptoms rather
than at prolonging life. As other researchers, we noted
that when caregivers considered using potentially life-
prolonging interventions, their decision was significantly
associated with a long-term survival prognosis [25].
However, we found no difference between patients with
and those without cancer, as reported by Van den Block
et al [26]. In summary, in contrast to Becker and collea-
gues who noted that comfort-focused care concerned
less than one dying patient out of two, our results indi-
cate that the Belgian physicians and nurses are willing
to limit aggressive treatments and to plan comprehen-
sive palliative care [27]. Our results also indicate that
the caregivers seem to be in agreement with the World
Health Organisation’s recommendation and tend to
integrate palliative care as soon as possible into
the course of illness, as reported by the majority of
European medical oncologists [1,12,28].
Another striking finding of our study was that antibio-
tics, blood transfusions, specific treatments for primary
disease, artificial nutrition, and transfer to the intensive
care unit were considered for, or given, to about 90%,
80%, 60%, 50% and 33% of the patients, respectively.
Several authors have already noted that in an acute care
hospital, such therapeutic interventions, considered as
comfort care, were continued for the majority of dying
patients [26,29,30]. However, as these studies were ret-
rospective charts reviews, the detailed reasons for the
therapeutic procedures could not be clearly determined.
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Figure 2 Survival prognosis according to disease. The first bar represents the distribution of life expectancy of all palliative patients whatever
the disease. The others display the distribution of survival prognosis for the most frequent underlying diseases.
Table 4 Physicians’ expectations from the treatment plan
Life
prolongation
n=6 5
(100%)
Improvement of
comfort
n = 179 (100%)
Pathology Cancer 32 (49.2%) 94 (52.5%) p =
0.6501
Non-
cancer
33 (50.8%) 85 (47.5%)
Age < 75
years
37 (56.9%) 72 (40.2%) p =
0.0204
≥ 75
years
28 (43.1%) 107 (59.8%)
Prognosis ≤ 3
months
5 (7.7%) 73 (40.8%) p <
0.0001
>3
months
56 (86.2%) 104 (58.1%)
≤ 1 year 33 (50.8%) 141 (78.8%) p =
0.0019
> 1 year 28 (43.1%) 36 (20.1%)
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clearly noted by the health care providers: transfusions
and antibiotics were used largely to alleviate symptoms;
whereas admission to the intensive care unit, artificial
nutrition, and specific disease-related treatments were
used more to prolong life. Undoubtedly, interventions
such as antibiotics may contribute to a better manage-
ment of distressing symptoms [31]. Furthermore, the
long-term prognosis of some patients and uncertainty
about the short-term prognosis in others may encourage
a mixed management strategy and an interaction
between a curative and palliative approach. Nevertheless,
in a setting where priority is given to life-supporting and
life prolonging activities, some of these interventions
may be considered invasive and futile [32]. Van Leeu-
wen et al, who observed oncology multidisciplinary
meetings discussing potentially life prolonging treat-
ments, came to the conclusions that before making a
decision, healthcare professionals should gather exten-
sive information about gains that may be expected from
an intervention [33]. If case of doubt about whether or
not to start or continue treatment, the patient’sw i s h
could be a decisive consideration. Unfortunately, the
purpose of our study was not to assess whether the
decisions of the interviewed healthcare professionals
were medically and ethically appropriate.
Conclusions
The ability of health care providers to recognise the
patient as “palliative” and their readiness to limit aggres-
sive treatment and plan palliative care is essential to
improve palliative care for hospitalised patients. The
main result of this article is that physicians and nurses
identified 10% of inpatients as “palliative” patients and
that they adopted a comfort care plan in 70% of cases.
Our results highlight that the palliative inpatient popula-
tion is multifaceted and that therapeutic procedures are
varied and complex. These findings may help in plan-
ning the organisation of palliative care in health care
systems. Models of care that embrace all end-of-life
paths and meet the common but also the specific needs
of every disease must be developed. Medical and nursing
staff also need to be educated and supported in provi-
sion of care so that palliative patients can live with com-
fort and dignity whatever their primary diagnosis or
their life expectancy. Another challenge is to determine
how many and which of the 10% of palliative in-patients
should have access to specialised palliative care services.
These issues are important and require careful consid-
eration if high quality of care is to be provided to all
patients at the end of life.
Additional material
Additional file 1: Questionnaire (English version). This file contains
the questionnaire used by the study nurses when interviewing the
caregivers.
Additional file 2: Questionnaire (French version). This file contains the
questionnaire used by the study nurses when interviewing the
caregivers.
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